Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase

Cancer Gene Therapy

Volumn 9, Issue 3, 2002, Pages 236-242

  Mizuguchi, Hiroyuki ^a   Hayakawa, Takao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Adenovirus vector; Fiber; Gene therapy; Herpes simplex virus thymidine kinase; Suicide gene therapy

Indexed keywords

ADENOVIRUS VECTOR; GANCICLOVIR; THYMIDINE KINASE;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FIBER; GENE TRANSFER; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; LIVER INJURY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE THERAPY;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS; SIMPLEXVIRUS;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; CAPSID; CAPSID PROTEINS; CELL SURVIVAL; FEMALE; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HUMANS; INTEGRINS; LIVER; LUCIFERASES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; RECEPTORS, VITRONECTIN; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0036200923     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700440     Document Type: Article

References (47)

1. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
2. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
3. Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates
4. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir
5. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
6. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors
7. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy
8. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma
9. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
10. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a phase I clinical trial in malignant mesothelioma
11. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies
12. The "bystander effect:" tumor regression when a fraction of the tumor mass is genetically modified
13. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
14. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: Role of gap-junctional intercellular communication
15. Adenoviral vectors for gene transfer
16. Advances in adenoviral vectors: From genetic engineering to their biology
17. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
18. Receptors mediating adenovirus attachment and internalization
19. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
20. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus
21. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob
22. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob
23. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
24. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide
25. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model
26. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors
27. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach
28. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes
29. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo
30. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration
31. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method
32. A simple method for constructing E1 and E1/E4 deleted recombinant adenovirus vector
33. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo
34. The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12
35. A simple and efficient method for purification of infectious recombinant adenovirus
36. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
37. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines
38. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models
39. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor
40. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma
41. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse
42. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants
43. Insertion of an RDG motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
44. Transduction of a fiber-mutant adenovirus for the HSVtk gene highly augments the cytopathic effect towards glioma
45. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity
46. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
47. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer